hexamethonium has been researched along with Proteinuria in 1 studies
Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.
Proteinuria: The presence of proteins in the urine, an indicator of KIDNEY DISEASES.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujita, M | 1 |
| Ando, K | 1 |
| Kawarazaki, H | 1 |
| Kawarasaki, C | 1 |
| Muraoka, K | 1 |
| Ohtsu, H | 1 |
| Shimizu, H | 1 |
| Fujita, T | 1 |
1 other study available for hexamethonium and Proteinuria
| Article | Year |
|---|---|
Sympathoexcitation by brain oxidative stress mediates arterial pressure elevation in salt-induced chronic kidney disease.
Topics: Animals; Antihypertensive Agents; Antioxidants; Blood Pressure; Brain; Cyclic N-Oxides; Heart Rate; | 2012 |